Avapritinib is an Orally Active KIT/PDGFRA Inhibitor for Cancer Research
KIT receptors belong to the Class III receptor tyrosine kinase (RTK) family, which also includes PDGFRA (platelet-derived growth factor receptor A) and CSF1R (colony stimulating factor 1 receptor). Stem cell…